ASCENTAGE
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-03-26
Christopher Layt
Analyst
Lucid Capital Markets
Equibles does not estimate personal net worth.
About Christopher Layt
Christopher Layt is recorded as Analyst at Lucid Capital Markets. Christopher Layt has spoken on 1 earnings call across 1 company, most recently for ASCENTAGE on March 26, 2026. The companies whose calls Christopher Layt spoke on are classified in the Healthcare sector.
Christopher Layt on recent calls
“And for Lesatoclax, would you be looking to partner that asset as well? Or are you pretty adamant about going alone with that asset?”
Affiliation history
-
Lucid Capital Markets
Analyst
Transcript header (unverified)
Current
Company network
Recent activity
-
Earnings call
亚盛医药2025年年度业绩发布会
ASCENTAGE